This inventor holds 1 USPTO granted patent. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Vered Cohen: Inventor in Cannabinoid-Based Research
Introduction
Vered Cohen is an inventor based in Haifa, Israel, associated with the Technion Research & Development Foundation Ltd. Her work includes research into cannabinoid-based approaches to treating diseases related to estrogen receptors. The provided information lists 1 patent associated with her.
Latest Patents
Cohen is named on the patent “Cannabinoids and Uses Thereof for Treatment of Estrogen Receptor Related Diseases.” The invention describes a pharmaceutical composition containing one or more cannabinoids, including a compound represented by Formula II. It also describes administering the composition to treat diseases related to estrogen receptors.
The patent further outlines a combination therapy using the Formula II compound alongside an estrogen receptor activation inhibitor. This approach is intended to sensitize subjects who are resistant to treatment with the inhibitor alone.
Career Highlights
Cohen’s listed patent reflects work at the intersection of cannabinoid research and potential therapeutic applications. Her affiliation with the Technion Research & Development Foundation Ltd. connects her work with an organization supporting research and development.
Collaborations
Cohen’s listed coworker is David Meiri. Their shared research context includes the patent concerning cannabinoids and estrogen receptor-related diseases.
Conclusion
Vered Cohen’s patent focuses on cannabinoid-based compositions and combination therapy as potential approaches to estrogen receptor-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile